Skip to Content

China Proposes Dynamic Adjustment of Investment Approval to Curb Disorderly Competition

Proposed reforms aim to dynamically adjust approval or filing authority for enterprise investments,...
April 15, 2026 by
Key Metrics

8.4

Heat Index
  • Impact Level
    Medium
  • Scope Level
    National
  • Last Update
    2026-04-15
Key Impacts
Positive Impacts (4)
China A-shares Industrial Policy-sensitive Equities
Steel Sector
State-owned Enterprises in Strategic Industries
Aluminum
Negative Impacts (13)
Manufacturing Sector
Cement Sector
Heavy Industry Sector
Coal Chemicals / Petrochemicals Sector
Battery Manufacturing Sector
Solar Manufacturing Sector
Total impacts: 17 | Positive: 4 | Negative: 13
Event Overview

Proposed reforms aim to dynamically adjust approval or filing authority for enterprise investments, addressing industrial development stages and capacity. Industries with significant disorderly competition may face suspension of approvals, with specific controls and time limits set. Emphasis is placed on inter-agency coordination.

Collect Records
China Proposes Dynamic Adjustment of Investment Approval Authority
2026-04-15 17:06

The 'Opinions on Deepening the Reform of the Investment Approval System' propose dynamically adjusting the approval or filing authority levels for enterprise investment projects based on the stage of industrial development and capacity warnings. For industries with prominent disorderly competition, approval or filing can be suspended with the consent of the State Council, and specific control requirements and time limits should be set. The document also emphasizes the need for coordination between project approval/filing and element funding policies. Projects that are prohibited will not receive land, energy, environmental impact assessment, and other guarantees, nor will they receive government investment and financing support. It is required that the approval authority for elements be adjusted in sync with the project approval authority.

Total records: 1
HIMS Stock Jumps 10% After FDA Plans to Relax Peptide Drug Regulations
Relaxation of regulatory standards for peptide drugs prompts a significant market response, with...